The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung-Reference-Cited by-同舟云学术

The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung

Published:2019-07 Issue:7 Volume:14 Page:1213-1222
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Chan Anthony W.,Chau Shuk L.,Tong Joanna H.,Chow Chit,Kwan Johnny S.H.,Chung Lau Y.,Lung Raymond W.,Tong Carol Y.,Tin Edith K.,Law Peggy P.,Law Wai T.,Ng Calvin S.H.,Wan Innes Y.P.,Mok Tony S.K.,To Ka Fai

Funder

AstraZeneca

Genentech

Bristol-Myers Squibb

Novartis

Pfizer

Chinese University of Hong Kong

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart;Travis,2004

2. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart;Travis,2015

3. Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology;Rossi;Virchows Arch,2014

4. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma;Rekhtman;Mod Pathol,2013

5. Dissecting pulmonary large-cell carcinoma by targeted next generation sequencing of several cancer genes pushes genotypic-phenotypic correlations to emerge;Pelosi;J Thorac Oncol,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large cell carcinoma of the lung: LDCT features and survival in screen-detected cases;European Journal of Radiology;2024-10

2. Comparison of treatment outcome between first‐line combination immunotherapy (anti‐PD‐L1 or anti‐PD1) with or without chemotherapy and chemotherapy alone in advanced non‐small cell lung cancer patients in tertiary care hospital;Cancer Medicine;2024-07

3. SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant;Pathology;2024-06

4. Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer;Pharmaceuticals;2024-05-08

5. The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults;Cancers;2024-04-29